UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Regulation of RIG-I-like receptor signaling by host and viral proteins

Cytokine & growth factor reviews, 2014-10, Vol.25 (5), p.491-505

2014

Volltextzugriff (PDF)

Antagonism of the Phosphatase PP1 by the Measles Virus V Protein Is Required for Innate Immune Escape of MDA5

Cell host & microbe, 2014-07, Vol.16 (1), p.19-30

2014

Volltextzugriff (PDF)

The ubiquitin-specific protease USP15 promotes RIG-I-mediated antiviral signaling by deubiquitylating TRIM25

Science signaling, 2014-01, Vol.7 (307), p.ra3

2014

Volltextzugriff (PDF)

Neutralization against BA.2.75.2, BQ.1.1, and XBB from mRNA Bivalent Booster

The New England journal of medicine, 2023-01, Vol.388 (2), p.183-185

2023

Volltextzugriff (PDF)

Measles Virus Suppresses RIG-I-like Receptor Activation in Dendritic Cells via DC-SIGN-Mediated Inhibition of PP1 Phosphatases

Cell host & microbe, 2014-07, Vol.16 (1), p.31-42

2014

Volltextzugriff (PDF)

An intranasal vaccine durably protects against SARS-CoV-2 variants in mice

Cell reports (Cambridge), 2021-07, Vol.36 (4), p.109452, Article 109452

2021

Volltextzugriff (PDF)

ISG15-dependent activation of the sensor MDA5 is antagonized by the SARS-CoV-2 papain-like protease to evade host innate immunity

Nature microbiology, 2021-04, Vol.6 (4), p.467-478

2021

Volltextzugriff (PDF)

mRNA-1273 and BNT162b2 mRNA vaccines have reduced neutralizing activity against the SARS-CoV-2 omicron variant

Cell reports. Medicine, 2022-02, Vol.3 (2), p.100529-100529, Article 100529

2022

Volltextzugriff (PDF)

Mutations derived from horseshoe bat ACE2 orthologs enhance ACE2-Fc neutralization of SARS-CoV-2

PLoS pathogens, 2021-04, Vol.17 (4), p.e1009501-e1009501

2021

Volltextzugriff (PDF)

Parvovirus minute virus of mice induces a DNA damage response that facilitates viral replication

PLoS pathogens, 2010-10, Vol.6 (10), p.e1001141-e1001141

2010

Volltextzugriff (PDF)

Ubiquitination in the antiviral immune response

Virology (New York, N.Y.), 2015-05, Vol.479, p.52-65

2015

Volltextzugriff (PDF)

Mouse-adapted SARS-CoV-2 protects animals from lethal SARS-CoV challenge

PLoS biology, 2021-11, Vol.19 (11), p.e3001284-e3001284

2021

Volltextzugriff (PDF)

Durability of immune responses to mRNA booster vaccination against COVID-19

The Journal of clinical investigation, 2023-05, Vol.133 (10), p.1-10

2023

Volltextzugriff (PDF)

eCD4-Ig promotes ADCC activity of sera from HIV-1-infected patients

PLoS pathogens, 2017-12, Vol.13 (12), p.e1006786-e1006786

2017

Volltextzugriff (PDF)

A Bispecific Antibody That Simultaneously Recognizes the V2- and V3-Glycan Epitopes of the HIV-1 Envelope Glycoprotein Is Broader and More Potent than Its Parental Antibodies

mBio, 2020-01, Vol.11 (1)

2020

Volltextzugriff (PDF)

CCR2 Signaling Restricts SARS-CoV-2 Infection

mBio, 2021-12, Vol.12 (6), p.e0274921-e0274921

2021

Volltextzugriff (PDF)

Antibody Response to COVID-19 mRNA Vaccine in Patients With Lung Cancer After Primary Immunization and Booster: Reactivity to the SARS-CoV-2 WT Virus and Omicron Variant

Journal of clinical oncology, 2022-11, Vol.40 (33), p.3808-3816

2022

Volltextzugriff (PDF)

Neutralizing antibody responses in patients hospitalized with SARS-CoV-2 Delta or Omicron infection

The Journal of clinical investigation, 2022-12, Vol.132 (23), p.1-3

2022

Volltextzugriff (PDF)

A wild boar cathelicidin peptide derivative inhibits severe acute respiratory syndrome coronavirus-2 and its drifted variants

Scientific reports, 2023-09, Vol.13 (1), p.14650-14650, Article 14650

2023

Volltextzugriff (PDF)

A strategy for high antibody expression with low anti-drug antibodies using AAV9 vectors

Frontiers in immunology, 2023-04, Vol.14, p.1105617-1105617

2023

Volltextzugriff (PDF)

Erratum for Vanderheiden et al., "CCR2 Signaling Restricts SARS-CoV-2 Infection"

mBio, 2022-04, Vol.13 (3), p.e0025922-e0025922

2022

Volltextzugriff (PDF)

High throughput screening for drugs that inhibit 3C-like protease in SARS-CoV-2

SLAS discovery, 2023-04, Vol.28 (3), p.95-101

2023

Volltextzugriff (PDF)

1 – 25 von 242

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(223)
Mit Volltextzugriff
(204)

Publikationsform

Sprache

Englisch
(240)
Deutsch
(1)
Russisch
(1)

Erscheinungsjahr

n.n

Thema

Science & Technology
(183)
Life Sciences & Biomedicine
(165)
Humans
(128)
Female
(72)
Male
(61)
Middle Aged
(45)
Adult
(43)
Aged
(38)
Animals
(34)
Adolescent
(33)
Biological And Medical Sciences
(24)
Young Adult
(24)
Covid-19
(21)
Medical Sciences
(20)
Mice
(20)
Aged, 80 And Over
(19)
Infections
(18)
Biochemistry & Molecular Biology
(17)
Child
(16)
Public, Environmental & Occupational Health
(15)

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

Cancer Research
(6)
Nature Communications
(5)
Biochemistry
(4)
Journal Of Clinical Oncology
(4)
Plos Pathogens
(4)
Cell
(3)
Cell Host & Microbe
(3)
Journal Of Natural Products
(3)
Mbio
(3)
Mmwr. Morbidity And Mortality Weekly Report
(3)

5 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 30 Tagen
(1)
... seit 90 Tagen
(9)

Menü

Weitere Dienste

Einstellungen

Regulation of RIG-I-like receptor signaling by host and viral proteins

Antagonism of the Phosphatase PP1 by the Measles Virus V Protein Is Required for Innate Immune Escape of MDA5

The ubiquitin-specific protease USP15 promotes RIG-I-mediated antiviral signaling by deubiquitylating TRIM25

Neutralization against BA.2.75.2, BQ.1.1, and XBB from mRNA Bivalent Booster

Infection- and vaccine-induced antibody binding and neutralization of the B.1.351 SARS-CoV-2 variant

Measles Virus Suppresses RIG-I-like Receptor Activation in Dendritic Cells via DC-SIGN-Mediated Inhibition of PP1 Phosphatases

An intranasal vaccine durably protects against SARS-CoV-2 variants in mice

ISG15-dependent activation of the sensor MDA5 is antagonized by the SARS-CoV-2 papain-like protease to evade host innate immunity

mRNA-1273 and BNT162b2 mRNA vaccines have reduced neutralizing activity against the SARS-CoV-2 omicron variant

Mutations derived from horseshoe bat ACE2 orthologs enhance ACE2-Fc neutralization of SARS-CoV-2

Parvovirus minute virus of mice induces a DNA damage response that facilitates viral replication

Ubiquitination in the antiviral immune response

Mouse-adapted SARS-CoV-2 protects animals from lethal SARS-CoV challenge

Durability of immune responses to mRNA booster vaccination against COVID-19

eCD4-Ig promotes ADCC activity of sera from HIV-1-infected patients

A Bispecific Antibody That Simultaneously Recognizes the V2- and V3-Glycan Epitopes of the HIV-1 Envelope Glycoprotein Is Broader and More Potent than Its Parental Antibodies

CCR2 Signaling Restricts SARS-CoV-2 Infection

Antibody Response to COVID-19 mRNA Vaccine in Patients With Lung Cancer After Primary Immunization and Booster: Reactivity to the SARS-CoV-2 WT Virus and Omicron Variant

Neutralizing antibody responses in patients hospitalized with SARS-CoV-2 Delta or Omicron infection

A wild boar cathelicidin peptide derivative inhibits severe acute respiratory syndrome coronavirus-2 and its drifted variants

A modified vaccinia Ankara vaccine expressing spike and nucleocapsid protects rhesus macaques against SARS-CoV-2 Delta infection

A strategy for high antibody expression with low anti-drug antibodies using AAV9 vectors

Structural insights for neutralization of Omicron variants BA.1, BA.2, BA.4, and BA.5 by a broadly neutralizing SARS-CoV-2 antibody

Erratum for Vanderheiden et al., "CCR2 Signaling Restricts SARS-CoV-2 Infection"

High throughput screening for drugs that inhibit 3C-like protease in SARS-CoV-2

Suchergebnisse filtern